Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Is APBI appropriate for patients with rare tumor histology (mucinous, medullary, or tubular) if they meet all other suitability criteria?
Answer from: Radiation Oncologist at Community Practice
If phenotype right then it is tubular and mutinous are ER positive low grade tumor and are good candidates for APBI.
Comments
Radiation Oncologist at Allegheny Health Network, Pittsburgh
Agreed, these patients are good candidates for APB...
Radiation Oncologist at Mallory Radiotherapy, PLLC
Hi, thanks for your replies! I asked this question...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Medullary is Associated with BRCA 1 mutation and c...
2481
2482
2483
Sign in or Register to read more
7005
Related Questions
When utilizing hypofractionated radiotherapy in the post mastectomy setting, are the nodal regions dose painted to a different dose or the same dose as the chest wall/reconstructed breast?
Would you consider partial breast irradiation in patients who otherwise meet PBI guidelines who have a pathogenic variant of CHEK2 or other moderate penetrance gene?
How would you manage a patient with micrometastatic node positive tumor post mastectomy (no neoadjuvant chemotherapy)?
In a patient with T2N0 breast cancer with skin involvement s/p lumpectomy and negative margins, if you are offering whole breast radiation, would you bolus your tangent fields?
In a young woman with large invasive breast carcinoma (case: pT3, lobular) s/p skin sparing mastectomy with positive anterior margin, what is the practical role for re-excision with or without PMRT?
Is it appropriate to use bolus with hypofractionated PMRT?
How do you advise patients on cardiotoxicity when they are expected to receive a low mean heart dose and low cardiac substructure doses with their radiation plan?
What is your preferred method of surveillance after mastectomy?
Would you recommend PMRT to a clinically node positive (biopsy proven axillary node and indeterminate single IMN node) BRCA positive patient with multiple medical co-morbidities including scleroderma and ILD who is treated with neoadjuvant chemotherapy (NAC) and mastectomy who converts to ypT0/ypN0?
Does delay to the time of lumpectomy impact your decision to omit radiation?
Agreed, these patients are good candidates for APB...
Hi, thanks for your replies! I asked this question...
Medullary is Associated with BRCA 1 mutation and c...